Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Reneo Pharmaceuticals Q2 EPS $(0.50) Down From $(0.43) YoY

Reneo Pharmaceuticals (NASDAQ:RPHM) reported quarterly losses of $(0.50) per share. This is a 16.28 percent decrease over losses of $(0.43) per share from the same period last year.
byBenzinga Newsdesk
August 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Reneo Pharmaceuticals (NASDAQ:RPHM) reported quarterly losses of $(0.50) per share. This is a 16.28 percent decrease over losses of $(0.43) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

MediciNova Received a Notice of Allowance for a New Patent Covering MN-001 and MN-002 for the Treatment of Hypertriglyceridemia, Hypercholesterolemia, and Hyperlipoproteinemia in Canada

By Charles Gross
September 13, 7:59 PM
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it has received a Notice of Allowance from the Canadian Intellectual Property Office for a pending patent application which covers MN-001 (tipelu

MNOV